LPL Financial LLC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$1,185,624
-22.8%
234,777
-23.1%
0.00%0.0%
Q2 2023$1,536,474
-23.9%
305,462
-6.9%
0.00%
-50.0%
Q1 2023$2,018,719
-59.6%
328,247
-13.3%
0.00%
-50.0%
Q4 2022$4,995,672
+241.0%
378,460
-23.3%
0.00%
+300.0%
Q3 2022$1,465,000
+106.3%
493,231
+153.6%
0.00%0.0%
Q2 2022$710,000
+4.9%
194,500
+328.1%
0.00%0.0%
Q3 2021$677,000
+5.6%
45,436
-11.0%
0.00%0.0%
Q2 2021$641,00051,0500.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders